Psychedelic Stocks Lobe Sciences Ltd (OTCMKTS:GTSIF) Signs LOI to Sell Cowlitz Asset for $23 Million To IONIC Brands By Larry Zweig January 06, 2021 Lobe Sciences Ltd (OTCMKTS:GTSIF) has announced receipt and signing a non-binding letter of intent with IONIC Brands Corp. The LOI is for the proposed sale of some of its assets related to Cowlitz County Cannabis Cultivation ink t...
Psychedelic Stocks New Wave Holdings Ltd’s (OTCMKTS:TRMNF) Joint Venture N2 Logics Acquire Stake In Bloom Botanics By Larry Zweig January 06, 2021 New Wave Holdings Ltd (OTCMKTS:TRMNF) has announced that N2 Logics Inc. in which it has a significant interest, has acquired a leading CBD and nutraceuticals online superstore that distributes health and wellness products. N2 Logi...
Psychedelic Stocks Mindset Pharma Files For A Provisional Patent For A New Psychedelic-based Pipeline Drug By Larry Zweig January 05, 2021 Mindset Pharma is on the fast track in the race for psychedelics-based medicines and it is rapidly expanding its portfolio. It is one of the companies that are aggressively pushing into the new frontier of medical research involvi...
Psychedelic Stocks UK-Based Small Pharma Secures Regulatory Green Light To Investigate DMT’s Potential Therapeutic Properties By Larry Zweig January 05, 2021 Psychedelics such as dimethyltriptamine (DMT) have been gaining popularity not only due to the euphoria they provide but also because they are claimed to have therapeutic properties. UK regulators have weighed in on those claims a...
Psychedelic Stocks Ehave Inc. (OTCMKTS:EHVVF) Brings CureDash Platform Into KetaDASH to Enable IV administration of Ketamine By Larry Zweig January 05, 2021 Ehave Inc. (OTCMKTS:EHVVF) has announced KetaDASH www.ketadash.com which is an intravenous based home delivery platform for Ketamine prescriptions. Ehave giving practitioners a way to administer ketamine The company has signed an...
Psychedelic Stocks Mydecine Innovations Group (OTCMKTS:MYCOF) Contracts ethica CRO To Lead Phase 2a PTSD Clinical Trials By Larry Zweig January 05, 2021 Mydecine Innovations Group (OTCMKTS:MYCOF) has announced the engagement of ethica CRO as its contract research organization for its Phase 2a PTSD clinical studies. Ethica CRO is a full-service CRO that conducts and also managed et...
Psychedelic Stocks Psychedelic Companies Accelerating Their Mental illness Programs Following Approval Of Johnson & Johnson’s (NYSE:JNJ) Depression Treatment By Larry Zweig January 05, 2021 The psychedelic medicines industry saw tremendous growth in 2020 and the growth could continue in 2021 as more cases of mental illness continue globally. The World Health Organisation has estimated that each year there are more th...
Psychedelic Stocks Wuhan General Group Inc. (OTCMKS:WUHN) Venturing Into Hemp Market With the Launch of M2BIO Hemp Division By Larry Zweig January 05, 2021 Wuhan General Group Inc. (OTCMKS:WUHN) has announced that it is venturing into the hemp industry. The psilocybin medical research and plant-based cannabinoids company have launched M2BIO Hemp Product Research and Development Divis...